Development of a P2X3 receptor antagonist derived from eliapixant with improved properties for the treatment of chronic cough.
- DOI
- 10.1016/j.ejmech.2025.118116
- Published
- 2025 Dec 15
- Container
- European journal of medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejmech.2025.118116,
title = {Development of a P2X3 receptor antagonist derived from eliapixant with improved properties for the treatment of chronic cough.},
author = {Zang Y and Li Q and Li Y and Ding X and Liu R and Liu L and Sun H and Qu L and Zhang X},
year = {2025},
journal = {European journal of medicinal chemistry},
doi = {10.1016/j.ejmech.2025.118116},
url = {https://doi.org/10.1016/j.ejmech.2025.118116}
}RIS
TY - JOUR TI - Development of a P2X3 receptor antagonist derived from eliapixant with improved properties for the treatment of chronic cough. AU - Zang Y AU - Li Q AU - Li Y AU - Ding X AU - Liu R AU - Liu L AU - Sun H AU - Qu L AU - Zhang X PY - 2025 JO - European journal of medicinal chemistry DO - 10.1016/j.ejmech.2025.118116 UR - https://doi.org/10.1016/j.ejmech.2025.118116 ER -
APA
Y, Z., Q, L., Y, L., X, D., R, L., L, L., H, S., L, Q., & X, Z. (2025). Development of a P2X3 receptor antagonist derived from eliapixant with improved properties for the treatment of chronic cough.. European journal of medicinal chemistry. https://doi.org/10.1016/j.ejmech.2025.118116
Source records
- pubmed · retrieved 2026-09-26T22:11:00.755Z